Dosimetric rationale and early experience at UFPTI of thoracic proton therapy and chemotherapy in limited-stage small cell lung cancer

Acta Oncologica

Volumn 52, Issue 3, 2013, Pages 506-513

  Colaco, Rovel J ^a   Huh, Soon ^a   Nichols, Romaine C ^a   Morris, Christopher G ^a   D'Agostino, Harry ^b   Flampouri, Stella ^a   Li, Zuofeng ^a   Pham, Dat C ^b   Bajwa, Abubakr A ^b   Hoppe, Bradford S ^a  

^a UNIVERSITY OF FLORIDA   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENAL METASTASIS; ADULT; AGED; ANOREXIA; ARTICLE; BONE METASTASIS; BRONCHOSCOPY; CANCER CHEMOTHERAPY; CANCER STAGING; CHEMORADIOTHERAPY; CLINICAL ARTICLE; COUGHING; DISTANT METASTASIS; DOSIMETRY; DYSPHAGIA; DYSPNEA; ESOPHAGITIS; ESOPHAGUS; FATIGUE; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HUMAN; HYPOXIA; INTENSITY MODULATED RADIATION THERAPY; LIVER METASTASIS; LUNG FIBROSIS; LUNG SMALL CELL CANCER; MALE; MEDIASTINOSCOPY; MEDICAL RECORD REVIEW; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PNEUMONIA; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; PROTON THERAPY; RADIATION DERMATITIS; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RADIATION INJURY; RADIATION SICKNESS; RETROSPECTIVE STUDY; SKULL IRRADIATION; TREATMENT PLANNING; VOMITING; ACUTE TOXICITY; ASSESSMENT OF HUMANS; ATRIAL FIBRILLATION; BLOOD TOXICITY; CANCER SURVIVAL; CASE STUDY; COMMON TERMINOLOGY CRITERIA FOR ADVERSE EVENT; COMPARATIVE STUDY; COMPUTER ASSISTED RADIOTHERAPY; CORTICOSTEROID INDUCED MYOPATHY; DERMATITIS; DISEASE EXACERBATION; ESOPHAGUS STENOSIS; MEDICAL HISTORY; MIDDLE AGED; NAUSEA; OXYGEN THERAPY; RADIOTHERAPY PLANNING SYSTEM; RECURRENCE FREE SURVIVAL; SMALL CELL LUNG CANCER; TUMOR VOLUME; WEIGHT REDUCTION;

AGED; CHEMORADIOTHERAPY; FLORIDA; FOLLOW-UP STUDIES; HOSPITALS, UNIVERSITY; HUMANS; LUNG NEOPLASMS; MIDDLE AGED; NEOPLASM STAGING; PROTON THERAPY; RADIATION INJURIES; RADIOTHERAPY DOSAGE; RETROSPECTIVE STUDIES; SMALL CELL LUNG CARCINOMA; TIME FACTORS;

ANTIEMETIC AGENT; CISPLATIN; ETOPOSIDE; STEROID;

EID: 84875157456     PISSN: 0284186X     EISSN: 1651226X     Source Type: Journal    
DOI: 10.3109/0284186X.2013.769063     Document Type: Article

References (31)

1. Stahel R, Ginsberg R, Havemann K, H irsch F R, I hde D C, Jassem J . Staging and prognostic factors in small cell lung cancer: A consensus report . Lung Cancer 1989; 5 : 119-26 (Pubitemid 20053516)
2. De Ruysscher D, P ijls-Johannesma M, V ansteenkiste J, Kester A, Rutten I, Lambin P . Systematic review and metaanalysis of randomised, controlled trials of the timing of chest radiotherapy in patients with limited-stage, small-cell lung cancer . Ann Oncol 2006; 17 : 543-52
3. Fried DB, M orris DE, P oole C, R osenman JG, H alle JS, Detterbeck FC, et al . Systematic review evaluating the timing of thoracic radiation therapy in combined modality therapy for limited-stage small-cell lung cancer . J Clin Oncol 2004; 22 : 4837-45
4. Huncharek M, M cGarry R. A meta-analysis of the timing of chest irradiation in the combined modality treatment of limited-stage small cell lung cancer . Oncologist 2004; 9 : 665-72 (Pubitemid 39549328)
5. Baka S, C alifano R, F erraldeschi R, A schroft L, T hatcher N, Taylor P, et al . Phase III randomised trial of doxorubicinbased chemotherapy compared with platinum-based chemotherapy in small-cell lung cancer . Br J Cancer 2008; 99 : 442-7
6. Jeremic B. S hibamoto Y, A cimovic L, M ilisavljevic S . Initial versus delayed accelerated hyperfractionated radiation therapy and concurrent chemotherapy in limited small-cell lung cancer: A randomized study . J Clin Oncol 1997; 15 : 893-900 (Pubitemid 27106269)
7. Takada M, F ukuoka M, K awahara M, S ugiura T, Yokoyama A, Yokota S, et al . Phase III study of concurrent versus sequential thoracic radiotherapy in combination with cisplatin and etoposide for limited-stage small-cell lung cancer: Results of the Japan Clinical Oncology Group Study 9104 . J Clin Oncol 2002; 20 : 3054-60 (Pubitemid 34791094)
8. Turrisi A T, 3rd, K im K, B lum R, S ause WT, L ivingston RB, Komaki R, et al . Twice-daily compared with once-daily thoracic radiotherapy in limited small-cell lung cancer treated concurrently with cisplatin and etoposide . New Engl J Med 1999; 340 : 265-71 (Pubitemid 29063268)
9. Bonner JA, S loan JA, S hanahan T G, B rooks BJ, M arks RS, Krook JE, et al . Phase III comparison of twice-daily splitcourse irradiation versus once-daily irradiation for patients with limited stage small-cell lung carcinoma . J Clin Oncol 1999; 17 : 2681-91 (Pubitemid 29415224)
10. Grutters J P, K essels A G, P ijls-Johannesma M, De Ruysscher D, Joore MA, Lambin P . Comparison of the effectiveness of radiotherapy with photons, protons and carbon-ions for non-small cell lung cancer: A meta-analysis . Radiother Oncol 2010; 95 : 32-40
11. Nakayama H, S ugahara S, T okita M, S atoh H, T suboi K, Ishikawa S, et al . Proton beam therapy for patients with medically inoperable stage I non-small-cell lung cancer at the university of tsukuba . Int J Radiat Oncol Biol Phys 2010; 78 : 467-71
12. Chang JY, Z hang X, W ang X, K ang Y, R iley B, B ilton S, et al . Signifi cant reduction of normal tissue dose by proton radiotherapy compared with three-dimensional conformal or intensity-modulated radiation therapy in Stage I or Stage III non-small-cell lung cancer . Int J Radiat Oncol Biol Phys 2006; 65 : 1087-96
13. Nichols R CJ, H uh S H, H enderson R H, Z uofeng L, Flampouri S, D'Agostino HJ, et al . Selective nodal irradiation of regionally advanced non-small-cell lung cancer with proton therapy and IMRT: A dosimetric comparison . Thorac Cancer 2012; 3 : 169-74
14. O shiro Y, M izumoto M, O kumura T, H ashimoto T, Fukumitsu N, Ohkawa A, et al . Results of proton beam therapy without concurrent chemotherapy for patients with unresectable stage III non-small cell lung cancer . J Thorac Oncol 2012 ; 7 : 370-5
15. Hoppe BS, F lampouri S, H enderson RH, P ham D, Bajwa AA, D'Agostino H, et al . Proton therapy with concurrent chemotherapy for non-small-cell lung cancer: Technique and early results . Clin Lung Cancer 2012; 13 : 352-8
16. Chang JY, K omaki R, L u C, W en HY, A llen PK, T sao A, et al . Phase 2 study of high-dose proton therapy with concurrent chemotherapy for unresectable stage III nonsmall cell lung cancer . Cancer 2011; 117 : 4707-13
17. TNM staging for lung cancer. A JCC Cancer Staging Manual, 7th ed . Chicago, IL: Springer; 2010
18. Yeung AR, L i J, S hi W, N ewlin H, M orris C G, S amant S, et al . Optimal image-guidance scenario with conebeam computed tomography in conventionally fractionated radiotherapy for lung tumors . Am J Clin Oncol 2010; 33 : 276-80
19. Kang Y, Z hang X, C hang J Y, W ang H, W ei X, L iao Z, et al . 4D Proton treatment planning strategy for mobile lung tumors . Int J Radiat Oncol Biol Phys 2007; 67 : 906-14 (Pubitemid 46215899)
20. De Ruysscher D, B remer R H, K oppe F, W anders S, van Haren E, Hochstenbag M, et al . Omission of elective node irradiation on basis of CT-scans in patients with limited disease small cell lung cancer: A phase II trial . Radiother Oncol 2006; 80 : 307-12 (Pubitemid 44397204)
21. Baas P, Belderbos JS [21], S enan S, K wa HB, v an Bochove A, van Tinteren H, et al . Concurrent chemotherapy (carboplatin, paclitaxel, etoposide) and involved-fi eld radiotherapy in limited stage small cell lung cancer: A Dutch multicenter phase II study . Br J Cancer 2006; 94 : 625-30 (Pubitemid 43361891)
22. van Loon J, D e Ruysscher D, W anders R, Boersma L, Simons J, Oellers M, et al. Selective nodal irradiation on basis of (18) FDG-PET scans in limited-disease small-cell lung cancer: A prospective study. Int J Radiat Oncol Biol Phys 2010; 77 : 329-36
23. Shirvani SM, K omaki R, H eymach JV, F ossella FV, C hang JY . Positron emission tomography/computed tomographyguided intensity-modulated radiotherapy for limitedstage small-cell lung cancer . Int J Radiat Oncol Biol Phys 2012; 82 : E91-7
24. Colaco R, S heikh H, L origan P, B lackhall F, H ulse P, Califano R, et al . Omitting elective nodal irradiation during thoracic irradiation in limited-stage small cell lung cancer-evidence from a phase II trial . Lung Cancer 2012; 76 : 72-7
25. Liao Z, L in SH, C ox JD. Status of particle therapy for lung cancer. Acta Oncol 2011; 50 : 745-56
26. Giroux Leprieur E, F ernandez D, C hatellier G, K lotz S, Giraud P, Durdux C . Non-small cell lung cancer: Risk factors of radiation pneumonitis . Cancer Radiother 2012; 16 : 257-62
27. Gomez DR, T ucker SL, M artel MK, M ohan R, B alter PA, Lopez Guerra JL, et al . Predictors of high-grade esophagitis after defi nitive three-dimensional conformal therapy, intensity- modulated therapy, or proton beam therapy for non-small cell lung cancer . Int J Rad Oncol Biol Phys 2012; 84 : 1010-6
28. Kalemkerian G P, A kerley W, B ogner P, B orghaei H, C how LQ, Downey RJ, et al . Small cell lung cancer . JNCCN 2013 ; 11 : 78-98
29. Nichols R C, H uh S N, H enderson R H, M endenhall NP, Flampouri S, Li Z, et al . Proton radiation therapy offers reduced normal lung and bone marrow exposure for patients receiving dose-escalated radiation therapy for unresectable stage III non-small-cell lung cancer: A dosimetric study . Clin Lung Cancer 2011; 12 : 252-7
30. Nichols R C, H uh S H, H oppe B S, H enderson R H, Li Z, Flampouri S, et al . Protons safely allow coverage of highrisk nodes for patients with regionally advanced non-small-cell lung cancer . Technol Cancer Res Treat 2011; 10 : 317-22
31. Nichols RC, H enderson RH, H uh S, F lampouri S, Zuofeng L, Bajwa AA, et al . Proton therapy for lung cancer . Thorac Cancer 2012; 3 : 109-16